Truelife Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 29-06-2024
- Revenue 53.37%
(FY 2022)
- Profit 60.64%
(FY 2022)
- Ebitda -120.73%
(FY 2022)
- Net Worth 25.67%
(FY 2022)
- Total Assets 33.97%
(FY 2022)
About Truelife Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Visatkumar Patel, Rahul Dabhi, Priya Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2014PTC080112
- Company No.
080112
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Truelife Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Dabhi  | Director | 02-Jan-2017 | Current |
| Avinash Patel | Director | 14-Jul-2014 | Current |
| Visatkumar Patel | Director | 02-Jan-2017 | Current |
| Priya Patel | Director | 23-Nov-2016 | Current |
Financial Performance of Truelife Pharma.
Truelife Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.37% increase. The company also saw a substantial improvement in profitability, with a 60.64% increase in profit. The company's net worth Soared by an impressive increase of 25.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Truelife Pharma?
Unlock access to Truelife Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Sep 2023 | ₹4.00 M | Open |
How Many Employees Work at Truelife Pharma?
Truelife Pharma has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Truelife Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truelife Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
